Skip to content

Clinical trials

Completed Phase 2 Chronic Limb-Threatening Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Phase: Phase 2 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20061
20071
20085
20101
20112
20123
20132
20142
20171
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AnGes USA, Inc.3
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2
Beijing Northland Biotech. Co., Ltd.1
Flanders Medical Research Program1
Helixmith Co., Ltd.1
Hemostemix1
Johann Wolfgang Goethe University Hospital1
Juventas Therapeutics, Inc.1
Lifecells, LLC.1
Lisata Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia23
Peripheral Vascular Diseases8
Arterial Occlusive Diseases4
Ischemia4
Peripheral Arterial Disease4
Thromboangiitis Obliterans2
Ulcer2
Vascular Diseases2
Diabetes Mellitus1
Diabetic Foot1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.